Table 4 Evaluate the efficacy of early oral doxycycline using PSM analysis
DOX + ATD1 group | ATD2 group | p-value | |
|---|---|---|---|
n = 28 | n = 28 | ||
Age, years | 9 (9, 10) | 10 (9, 10) | 0.447 |
Male gender | 13 (46%) | 16 (57%) | 0.422 |
Fever duration before treatment(d) | 3 (2, 5) | 3 (2, 4) | 0.326 |
Chest radiograph findings (n, %) | 0.783 | ||
Lobar consolidation | 17 (61%) | 18 (64%) | |
Patchy | 11 (39%) | 10 (36%) | |
Hospitalization duration(d) | 7 (6, 8) | 8 (7, 9) | 0.037 |
Fever duration after treatment(d) | 3 (2, 4) | 4 (3, 5) | 0.027 |
Defervescence within 72 h (n, %) | 16 (57%) | 8 (29%) | 0.031 |
Glucocorticoid(n,%) | 2 (7%) | 12 (43%) | 0.002 |